Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (Mpro)
Scientific Reports · 2024
DOI: 10.1038/s41598-024-57795-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Deepika Geedkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Sciences, Devi Ahilya University, Indore, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Antiviral Agents, SARS-CoV-2, Coronavirus 3C Proteases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The present work elicits a novel approach to combating COVID-19 by synthesizing a series of azo-anchored 3,4-dihydroimidazo[4,5- b ]indole derivatives. The envisaged methodology involves the l -proline-catalyzed condensation of para -amino-functionalized azo benzene, indoline-2,3-dione, and ammonium acetate precursors with pertinent aryl aldehyde derivatives under ultrasonic conditions. The structures of synthesized compounds were corroborated through FT-IR, 1 H NMR, 13 C NMR, and mass analysis data. Molecular docking studies assessed the inhibitory potential of these compounds against the main protease (M pro ) of SARS-CoV-2. Remarkably, in silico investigations revealed significant inhibitory action surpassing standard drugs such as Remdesivir, Paxlovid, Molnupiravir, Chloroquine, Hydroxychloroquine (HCQ), and (N3), an irreversible Michael acceptor inhibitor. Furthermore, the highly active compound was also screened for cytotoxicity activity against HEK-293 cells and exhibited minimal toxicity across a range of concentrations, affirming its favorable safety profile and potential suitability. The pharmacokinetic properties (ADME) of the synthesized compounds have also been deliberated. This study paves the way for in vitro and in vivo testing of these scaffolds in the ongoing battle against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemical Sciences, Devi Ahilya University, Indore, Madhya Pradesh, India.
- School of Chemical Sciences, Devi Ahilya University, Indore, Madhya Pradesh, India. drpratibhasharma@yahoo.com.
Zitieren
APA
Geedkar, D., Kumar, A., & Sharma, P. (2024). Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (Mpro). Scientific Reports. https://doi.org/10.1038/s41598-024-57795-4
Vancouver
Geedkar D, Kumar A, Sharma P. Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (Mpro). Scientific Reports. 2024. doi:10.1038/s41598-024-57795-4
BibTeX
@article{Geedkar2024,
author = {Geedkar, Deepika and Kumar, Ashok and Sharma, Pratibha},
title = {Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (Mpro)},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-57795-4}
}
EUVIMED